Medical News Today: Can we halt cellular aging? New drug combo shows promise
The story below features research Anoop Nambiar, M.D., M.S., on a new class of drugs called senolytics that were studied in relation to idiopathic pulmonary fibrosis. Dr. Nambiar is a professor of medicine and founding director of the Interstitial Lung Disease Program at UT Health San Antonio.
Two other faculty members are mentioned in the story:
- Miranda Orr, Ph.D., assistant professor of pharmacology, and her research using senolytics in Alzheimer’s disease, and
- Nicolas Musi, M.D., professor of medicine and director of the Sam and Barshop Institute for Longevity and Aging Studies. Dr. Musi was quoted but not associated with UT Health San Antonio.
Aging cells can become toxic to surrounding tissue, thus leading to numerous health problems. A class of drugs scientists call senolytics could help address these health issues, and improve symptoms.
Can a new drug combination help fight off the ill effects of cellular aging?….read more click here